Bull of the Day: Eastman Chemical (EMN)

Eastman Chemical’s (EMN) diversified chemical portfolio is driving earnings. The company benefits from business restructuring and cost-cutting measures. The Performance Chemicals business continues to outperform with an enhanced product mix achieved from the Genovique Specialty acquisition. Strong Specialty margins look increasingly credible.

diversified chemical portfolio is driving earnings. The company benefits from business restructuring and cost-cutting measures. The Performance Chemicals business continues to outperform with an enhanced product mix achieved from the Genovique Specialty acquisition. Strong Specialty margins look increasingly credible.

We are also getting optimistic about the Performance Polymer business, where Eastman has reversed losses. We are positive on the company s plans of divesting its PET business under the segment. We upgrade Eastman to Outperform from the previous Neutral recommendation and raise our target price to $77.00 from the initial $58.00.

EASTMAN CHEM CO (EMN): Free Stock Analysis Report

About Zacks Investment Research 1767 Articles

Zacks Investment Research is one of the most highly regarded firms in the investment industry. In 1978 Zacks originated the concept of utilizing earnings estimates revisions to make profitable investment decisions. Zacks offers multiple investment products and services to help investors achieve superior returns.

Visit: Zacks.com

Be the first to comment

Leave a Reply

Your email address will not be published.


*